Skip to product information
1 of 1

ARA-290 10mg | Cibinetide EPO-Derived Research Peptide

ARA-290 10mg | Cibinetide EPO-Derived Research Peptide

Regular price $80.00 USD
Regular price Sale price $80.00 USD
Sale Sold out
Quantity

ARA-290 (Cibinetide) | 10mg | Research Use Only

11 amino acids. Derived from EPO. That's the starting point for ARA-290.

ARA-290 also called Cibinetide is a synthetic peptide. It comes from structural regions of erythropoietin (EPO). Not EPO itself. A short sequence pulled from it. 11 amino acids total. In research literature it gets classified as a peptide inhibitor. The specific area researchers focus on is its interaction with the innate repair receptor the IRR.

What's the IRR? It's a receptor complex. Two parts: the erythropoietin receptor (EPOR) and the beta common receptor (βcR). Together they form the IRR. ARA-290 is designed as a selective agonist for that complex. In lab models, researchers study what happens when that receptor complex activates specifically around inflammatory and oxidative signaling pathways in vitro.

Lab only. Not for humans. Not for animals. Period.

The basics:

Full name: ARA-290 (Cibinetide)
Category: Peptide inhibitor
Formula: C51H84N16O21
Weight: 1257.3 g/mol
Form: Solid powder
Storage: -20°C

What the research covers:

IRR receptor interaction modeling is the main focus. EPO-derived signaling pathway work comes alongside it. Cytokine pathway analysis in non-human systems uses it too. Oxidative signaling cascade research is another area. Structure-activity relationship studies round it out researchers use ARA-290 to understand how EPO-derived sequences affect receptor behavior when stripped down to a short synthetic fragment.

One thing worth knowing: ARA-290 has received orphan drug designation from the FDA in specific investigational contexts. That's not the same as approval. Orphan designation means the FDA acknowledged it for rare disease investigation it does not authorize therapeutic use or commercial medical distribution. When supplied as a raw research peptide, it's a lab compound. Nothing more.

Researchers working on other short-chain bioregulator peptides may also find our Bronchogen 20mg AEDL tetrapeptide peptide bioregulator worth looking at.

Not FDA approved for general use. Can't diagnose, treat, cure, or prevent anything. Sold for lab research only. Period.

Not a supplement. Not a pharmaceutical. Purchase restricted to qualified research professionals with proper facilities. Read the terms before ordering.

Keep away from kids. Use proper lab equipment. Limited long-term safety data exists. Handle only if you're qualified. Buying means you take full responsibility for lawful and proper research use.

View full details